# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k123726   
B. Purpose for Submission: Addition of urine sample type to the already cleared device (k100853)   
C. Measurand: Sodium, Potassium, and Chloride   
D. Type of Test: Quantitative, indirect potentiometric measurement with ion-selective electrodes   
E. Applicant: Roche Diagnostics   
F. Proprietary and Established Names: cobas 8000 ISE Indirect Na, K, Cl for Gen. 2.   
G. Regulatory Information:

1. Regulation section: 21CFR 862.1665: Ion Specific Electrode, Sodium 21CFR 862.1600: Ion Specific Electrode, Potassium 21CFR 862.1170: Ion Specific Electrode, Chloride

2. Classification: Class II

3. Product code: JGS CEM CGZ

4. Panel: 75 (Clinical Chemistry)

# H. Intended Use:

1. Intended use(s): See Indication(s) for use below.

2. Indication(s) for use:

The cobas 8000 ISE module is a fully automated ion-specific analyzer intended for the in vitro potentiometric determination of chloride, potassium, and sodium in serum, plasma, and urine using ion-selective electrodes. Measurements obtained by this device are used in the diagnosis and treatment of diseases or conditions involving electrolyte imbalance.

3. Special conditions for use statement(s): For in vitro diagnostic use only. For prescription use.

4. Special instrument requirements: cobas 8000 ISE Modular Analyzer

# I. Device Description:

The cobas 8000 Modular Analyzer Series is a fully automated system for clinical chemistry analysis intended for the in vitro quantitative/qualitative determination of analytes in body fluids. It is optimized for high throughput workloads using a combination of ion selective electrodes (cobas 8000 1SE module) and photometric analysis modules (cobas c 701 and c 502 modules). The cobas 8000 ISE module and the ISE Gen 2 reagents were previously cleared for serum and plasma sample types under k100853. The ISE module includes a sodium electrode, a chloride electrode, a potassium electrode, a reference electrode, an ISE diluent, an ISE internal standard, an ISE reference electrolyte, an ISE calibrator and an ISE Compensator (calibrator). The ISE standard calibrators (S1, S2, and S3) were cleared under k053165 and ISE Compensator cleared under k052193.

# J. Substantial Equivalence Information:

1. Predicate device name(s): COBAS INTEGRA ISE System

2. Predicate 510(k) number(s): k963627

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities and Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Predicate deviceCOBAS INTEGRA ISEk963627</td><td colspan="1" rowspan="1">Candidate devicecobas 8000 ISE Module</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The COBAS INTEGRA ISEmodule applications are intended</td><td colspan="1" rowspan="1">Same (only for sodium,potassium and chloride, no</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">for use for the quantitativedetermination of sodium,potassium, chloride, and lithiumin serum, plasma or urine usingion-selective electrodes.</td><td colspan="1" rowspan="1">lithium)</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Serum, Plasma, Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">MeasurementPrinciple</td><td colspan="1" rowspan="1">ISE Potentiometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Reagentcontainer</td><td colspan="1" rowspan="1">Plastic bottles closed via screwcaps</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Onboardstoragetemperature</td><td colspan="1" rowspan="1">Room Temperature</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">ISE Module</td><td colspan="1" rowspan="1">Integrated into Integra analyzer</td><td colspan="1" rowspan="1">Separate ISE moduleconnected to Core cobas8000 module</td></tr><tr><td colspan="1" rowspan="1">Ion SelectiveElectrodes(ISEs)</td><td colspan="1" rowspan="1">Potentiometric chloride,potassium, sodium and referenceelectrodes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Dilution</td><td colspan="1" rowspan="1">1:6</td><td colspan="1" rowspan="1">1:46</td></tr><tr><td colspan="1" rowspan="1">Throughput</td><td colspan="1" rowspan="1">Max 600 tests/hour</td><td colspan="1" rowspan="1">Max 1800 tests/hour</td></tr><tr><td colspan="1" rowspan="1">DetectionLimits -Chloride</td><td colspan="1" rowspan="1">Not Determined</td><td colspan="1" rowspan="1">LOB = 10 mmol/LLOD = 10 mmol/LLOQ= 60 mmol/L</td></tr><tr><td colspan="1" rowspan="1">ReportableRange -Chloride</td><td colspan="1" rowspan="1">20-350 mmol/L</td><td colspan="1" rowspan="1">60-350 mmol/L</td></tr><tr><td colspan="1" rowspan="1">DetectionLimits -Potassium</td><td colspan="1" rowspan="1">Not Determined</td><td colspan="1" rowspan="1">LOB = 1 mmol/LLOD = 1 mmol/LLOQ = 3 mmol/L</td></tr><tr><td colspan="1" rowspan="1">ReportableRange -Potassium</td><td colspan="1" rowspan="1">1-150 mmol/L</td><td colspan="1" rowspan="1">3-100 mmol/L</td></tr><tr><td colspan="1" rowspan="1">DetectionLimits -Sodium</td><td colspan="1" rowspan="1">Not Determined</td><td colspan="1" rowspan="1">LOB = 10 mmol/LLOD = 10 mmol/LLOQ= 60 mmol/L</td></tr><tr><td colspan="1" rowspan="1">ReportableRange -Sodium</td><td colspan="1" rowspan="1">20-350 mmol/L</td><td colspan="1" rowspan="1">60-350 mmol/L</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

· CLSI EP5-A2: Evaluation of Precision Performance of Clinical Chemistry

Devices

· CLSI EP6-A: Evaluation of Linearity of Quantitative Analytical Methods · CLSI EP17-A: Protocols for Determination of Limits of Detection · CLSI EP17-A: Protocols for Determination of Limits of Detection

# L. Test Principle:

Sodium, Potassium and Chloride are measured using ion-selective electrodes utilizing an indirect (diluted) method where urine samples are automatically diluted at 1:46 ratio using ISE diluent. Each of the electrodes (Sodium, Potassium and Chloride) has membrane with an open liquid junction that is ion-selective. The reference electrode uses the same design of the ion-electrodes and it is exclusively used as a reference for every measurement. The difference of all voltages between the reference electrode and any ion-selective electrode is a measure for the concentration of individual ions. For every test, the voltages of both ISE internal standard and diluted sample solution are measured for each type of ions (Sodium, Potassium and Chloride). The measurement of all electrodes is performed in parallel. The resulting voltages are converted into operator readable results.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Precision studies were performed using human urine samples and control material. Within-run precision was determined using 21 replicates for each sample type (3 urine samples and 2 controls) by one operator on one instrument. Total precision was determined using 3 samples (Low, Medium and High) over 21 days in 2 runs with one operator on one instrument. The following results were obtained:

# Sodium

<table><tr><td rowspan=2 colspan=1>Sodium</td><td rowspan=1 colspan=3>Within-run precision</td><td rowspan=1 colspan=3>Total precision</td></tr><tr><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Urine low</td><td rowspan=1 colspan=1>66.4</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>68.6</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>Urine medium</td><td rowspan=1 colspan=1>178.9</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>180.3</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>Urine high</td><td rowspan=1 colspan=1>321.7</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>02</td><td rowspan=1 colspan=1>318.0</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>0.7</td></tr><tr><td rowspan=1 colspan=1>Liquichek 1</td><td rowspan=1 colspan=1>81.1</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>82.7</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>1.4</td></tr><tr><td rowspan=1 colspan=1>Liquichek 2</td><td rowspan=1 colspan=1>170.6</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>171.3</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.6</td></tr></table>

# Potassium

Chloride   

<table><tr><td rowspan=2 colspan=1>Potassium</td><td rowspan=1 colspan=3>Within-run precision</td><td rowspan=1 colspan=3>Total precision</td></tr><tr><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Urine low</td><td rowspan=1 colspan=1>3.65</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>3.75</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>Urine medium</td><td rowspan=1 colspan=1>51.10</td><td rowspan=1 colspan=1>0.30</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>49.48</td><td rowspan=1 colspan=1>0.65</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1>Urine high</td><td rowspan=1 colspan=1>83.78</td><td rowspan=1 colspan=1>0.66</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>80.60</td><td rowspan=1 colspan=1>1.32</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>Liquichek 1</td><td rowspan=1 colspan=1>32.19</td><td rowspan=1 colspan=1>0.19</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>31.32</td><td rowspan=1 colspan=1>0.37</td><td rowspan=1 colspan=1>1.2</td></tr><tr><td rowspan=1 colspan=1>Liquichek 2</td><td rowspan=1 colspan=1>69.47</td><td rowspan=1 colspan=1>0.39</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>67.49</td><td rowspan=1 colspan=1>1.17</td><td rowspan=1 colspan=1>1.7</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Chloride</td><td rowspan=1 colspan=3>Within-run precision</td><td rowspan=1 colspan=3>Total precision</td></tr><tr><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td><td rowspan=1 colspan=1>Meanmmol/L</td><td rowspan=1 colspan=1>SDmmol/L</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Urine low</td><td rowspan=1 colspan=1>63.6</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>64.7</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.7</td></tr><tr><td rowspan=1 colspan=1>Urine medium</td><td rowspan=1 colspan=1>180.8</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>179.7</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.7</td></tr><tr><td rowspan=1 colspan=1>Urine high</td><td rowspan=1 colspan=1>341.7</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>336.5</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>Liquichek 1</td><td rowspan=1 colspan=1>92.3</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>92.6</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.2</td></tr><tr><td rowspan=1 colspan=1>Liquichek 2</td><td rowspan=1 colspan=1>189.6</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>187.9</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>0.9</td></tr></table>

# b. Linearity/assay reportable range:

Linearity studies were performed according to CLSI EP6-A. Dilution series of 11 concentrations were prepared using low and high human urine sample pools for each of the analytes and tested in triplicates. Linear regression summary results of the study are presented in the table below:

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>r2</td><td rowspan=1 colspan=1>Range Tested</td></tr><tr><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>0.9914</td><td rowspan=1 colspan=1>3.1424</td><td rowspan=1 colspan=1>0.999957</td><td rowspan=1 colspan=1>54.6  368.8</td></tr><tr><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>1.0389</td><td rowspan=1 colspan=1>0.1518</td><td rowspan=1 colspan=1>0.999597</td><td rowspan=1 colspan=1>2.9 - 101.7</td></tr><tr><td rowspan=1 colspan=1>Chloride</td><td rowspan=1 colspan=1>0.9425</td><td rowspan=1 colspan=1>2.7004</td><td rowspan=1 colspan=1>0.999499</td><td rowspan=1 colspan=1>48 - 384.5</td></tr></table>

The results of the study support the sponsor’s claims that the urine Sodium is linear from $6 0 - 3 5 0 \mathrm { m m o l / L }$ , urine Potassium is linear from $\mathrm { 3 { - } 1 0 0 ~ m m o l / L }$ , and urine Chloride is linear form $6 0 { - } 3 5 0 \ \mathrm { m m o l / L }$ .

c. Traceability, Stability, Expected values (controls, calibrators, or methods): Aqueous ISE standard calibrators (S1, S2, and S3) were previously cleared under k053165 and ISE Compensator (calibrator) under k052193. The ISE Compensator is traceable to Flame Photometry (Sodium, Potassium) and Coulometry (Chloride).

# d. Detection limit:

Studies were carried out in accordance with CLSI Guidance Document EP17- A for Sodium, Potassium and Chloride analytes. For determination of LoB one analyte free sample was measured in 5 replicates, 6 runs, 3 days, on 2 cobas 8000 ISE analyzers. Total of 60 measurements were obtained per analyzer. For determination of LoD, five samples (one replicate) with lowanalyte concentration were measured in 6 runs for 3 days on 2 cobas 8000 ISE analyzer modules. In total 60 measurements were obtained per analyzer. For LoQ studies a low level sample set was prepared by diluting 3 human urine samples with an analyte free diluent (ISE Diluent). The low level sample set was tested in single replicate for 3 days in 2 runs per day on two cobas 8000 ISE analyzers. LoQ is defined as the concentration where total error is less than $20 \%$ . Results from the detection limit studies are summarized in the table below:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>LoB(mmol/L)</td><td rowspan=1 colspan=1>LoD(mmol/L)</td><td rowspan=1 colspan=1>LOQ(mmol/L)</td><td rowspan=1 colspan=1>Claimedmeasuring range(mmol/L)</td></tr><tr><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60-350</td></tr><tr><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3-100</td></tr><tr><td rowspan=1 colspan=1>Chloride</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60-350</td></tr></table>

# e. Analytical specificity:

Urine interference studies were performed in according to CLSI EP7-A2 for sodium, potassium, and chloride analytes using 2 levels of analytes (normal and abnormal). The effect of $\mathrm { p H } \left( 3 . 8 - 8 . 2 \right)$ , total protein $( 1 4 - 2 8 0 \mathrm { m g / L ) }$ , and hemoglobin $( 0 - 1 , 0 0 0 \mathrm { m g / d L } )$ on analyte recovery was evaluated in these studies. Different concentrations of potential interference substances were spiked into pooled urine samples. The sponsor’s definitions of non-significant interference is $< 1 0 \%$ difference between the spiked and unspiked samples. There was no significant interference for sodium, potassium, and chloride

when these analytes and interferents were tested in the concentration ranges indicated below:

Drug interferents: Acetaminophen (paracetamol) 3000 mg/L Ascorbic acid 4000 mg/L Ca-Dobesilate 1000 mg/L Gentamycin sulfate 400 mg/L Ibuprofen 4000 mg/L L-Dopa 1000 mg/L Methyldopa 2000 mg/L Na-Cefoxitin 12000 mg/L N-Acetylcysteine 10 mg/L Ofloxacine 900 mg/L Phenazopyridine 300 mg/L Salicyluric acid 6000 mg/L Tetracycline (Doxycycline) 300 mg/L

Hemolysis:   
Sodium and Chloride Hemoglobin in urine samples does not interfere in the tested concentration range up to $1 0 0 0 \mathrm { m g / d L }$ (621 umol/L) hemoglobin (approximate H index 1000).   
Potassium Hemoglobin levels higher than $4 0 0 \mathrm { m g / d L }$ in normal human urine samples increase the apparent potassium concentrations significantly. Hemoglobin in pathological urine samples does not interfere in the tested concentration range up to $1 0 0 0 \mathrm { m g / d l }$ (621 umol/L). Avoid hemolyzed specimens.

Icterus:

Bilirubin (conjugated) in urine samples does not interfere in the tested concentration range up to $6 0 \mathrm { m g / d l }$ $( 1 0 2 6 \mathrm { u m o l / L } )$ bilirubin (approximate I index 60).

<table><tr><td rowspan=2 colspan=1>Sample</td><td rowspan=2 colspan=1>pH</td><td rowspan=1 colspan=2>Sodium</td><td rowspan=1 colspan=2>Potassium</td><td rowspan=1 colspan=2>Chloride</td></tr><tr><td rowspan=1 colspan=1>Result(mmol/L)</td><td rowspan=1 colspan=1>% ofReference</td><td rowspan=1 colspan=1>Result(mmol/L)</td><td rowspan=1 colspan=1>% ofReference</td><td rowspan=1 colspan=1>Result(mmol/L)</td><td rowspan=1 colspan=1>% ofReference</td></tr><tr><td rowspan=1 colspan=1>Reference</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>74.4</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>27.32</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>70.0</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Acidic</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>74.2</td><td rowspan=1 colspan=1>99.7</td><td rowspan=1 colspan=1>26.77</td><td rowspan=1 colspan=1>97.99</td><td rowspan=1 colspan=1>72.6</td><td rowspan=1 colspan=1>103.7</td></tr><tr><td rowspan=1 colspan=1>Alkaline</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1>74.8</td><td rowspan=1 colspan=1>100.5</td><td rowspan=1 colspan=1>26.95</td><td rowspan=1 colspan=1>98.65</td><td rowspan=1 colspan=1>67.3</td><td rowspan=1 colspan=1>96.1</td></tr></table>

f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Method comparison studies were conducted for sodium, potassium and chloride on the candidate device (cobas 8000 ISE module) (y) and the results were compared to those determined with the predicate device analyzer (x). The lowest concentration and the highest concentration are diluted and spiked in order to cover hard-to-find sample range for each analyte. Results from the method comparison studies are summarized in tables below:

# Sodium

<table><tr><td rowspan=1 colspan=1>Instruments</td><td rowspan=1 colspan=1>No.Samples</td><td rowspan=1 colspan=1>Range Tested(mmol/L)</td><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>x:cobas INTEGRA ISEy:cobas 8000 ISE</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>62.2 - 340</td><td rowspan=1 colspan=1>y = 1.041x - 4.477</td><td rowspan=1 colspan=1>1.000</td></tr></table>

Potassium

<table><tr><td rowspan=1 colspan=1>Instruments</td><td rowspan=1 colspan=1>No.Samples</td><td rowspan=1 colspan=1>Range Tested(mmol/L)</td><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>x:cobas INTEGRA ISEy:cobas 8000 ISE</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>3.4- 100</td><td rowspan=1 colspan=1>y = 0.937x + 0.429</td><td rowspan=1 colspan=1> 1.000</td></tr></table>

Chloride

<table><tr><td rowspan=1 colspan=1>Instruments</td><td rowspan=1 colspan=1>No.Samples</td><td rowspan=1 colspan=1>Range Tested(mmol/L)</td><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=1 colspan=1>x:cobas INTEGRA ISEy:cobas 8000 ISE</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>61.1 - 344.3</td><td rowspan=1 colspan=1>y = 0.971x - 2.787 0.999</td><td rowspan=1 colspan=1>0.99</td></tr></table>

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable

c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not Applicable

5. Expected values1/Reference range: The expected values for adult based on 24 hours urine out-put are cited from the literature:

Na+ 40-220 mmol/24 h $\mathrm { K } +$ 25-125 mmol/24 h Cl- 110-250 mmol/24 h

References:

1. Tietz Fundamentals of Clinical Chemistry, Fifth Edition, Edited by Carl A. Burtis and Edward R. Ashwood, W.B. Saunders Company, 2001: 970, 1004, 1009 (ISBN 0-7216-8634-6).

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.